{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:17:47Z","timestamp":1794035867510,"version":"4.8.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003189","name":"Freemasons New Zealand","doi-asserted-by":"publisher","award":["3719321"],"award-info":[{"award-number":["3719321"]}],"id":[{"id":"10.13039\/501100003189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020396","name":"Alzheimers New Zealand","doi-asserted-by":"publisher","award":["3718869"],"award-info":[{"award-number":["3718869"]}],"id":[{"id":"10.13039\/501100020396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021732","name":"Aotearoa Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["3705579"],"award-info":[{"award-number":["3705579"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["3723033"],"award-info":[{"award-number":["3723033"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001543","name":"Neurological Foundation of New Zealand","doi-asserted-by":"publisher","award":["848010"],"award-info":[{"award-number":["848010"]}],"id":[{"id":"10.13039\/501100001543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroscience.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.neuroscience.2024.12.027","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T18:00:41Z","timestamp":1734372041000},"page":"87-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Upregulated excitatory amino acid transporter 1 (EAAT1) expression in the human medial temporal lobe in Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"566","author":[{"given":"Oliver W.G.","family":"Wood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.Y.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thulani H.","family":"Palpagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clinton","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Waldvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.M.","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kwakowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2024.12.027_b0005","first-page":"2023","author":"Alzheimer's Disease International","year":"2023","journal-title":"World Alzheimer Report"},{"key":"10.1016\/j.neuroscience.2024.12.027_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahr.2023.100169","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer's disease\u2013A step towards mitochondria based therapeutic strategies","author":"Aran","year":"2023","journal-title":"Aging Health Res."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00090","article-title":"Going the Extra (Synaptic) Mile: Excitotoxicity as the Road Toward Neurodegenerative Diseases","author":"Armada-Moreira","year":"2020","journal-title":"Front. Cell. Neurosci."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.027_b0020","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1523\/JNEUROSCI.14-09-05559.1994","article-title":"Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex","volume":"14","author":"Arriza","year":"1994","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.027_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/(SICI)1097-4547(19990115)55:2<218::AID-JNR9>3.0.CO;2-L","article-title":"Interindividual differences in the levels of the glutamate transporters GLAST and GLT, but no clear correlation with Alzheimer's disease","volume":"55","author":"Beckstr\u00f8m","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.027_b0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.celrep.2016.09.075","volume":"17","author":"Bhattarai","year":"2016","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.neuroscience.2024.12.027_b0035","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1093\/cercor\/bhy152","article-title":"Spreading of Tau Pathology in Sporadic Alzheimer's Disease Along Cortico-cortical Top-Down Connections","volume":"28","author":"Braak","year":"2018","journal-title":"Cereb. Cortex"},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.027_b0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.027_b0045","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/humu.24089","article-title":"Functional consequences of SLC1A3 mutations associated with episodic ataxia 6","volume":"41","author":"Chivukula","year":"2020","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","author":"Danbolt","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.027_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneurol.2008.535","article-title":"Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake","volume":"66","author":"de Vries","year":"2009","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.027_b0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.devbrainres.2005.01.005","article-title":"Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly","author":"Furuta","year":"2005","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-015-1532-2","article-title":"MCT4-Mediated Expression of EAAT1 is Involved in the Resistance to Hypoxia Injury in Astrocyte\u2013Neuron co-Cultures","author":"Gao","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.754743","article-title":"The Contribution of Dysfunctional Chloride Channels to Neurovascular Deficiency and Neurodegeneration","volume":"12","author":"Gascoigne","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer's disease: a prelude to the pathological process or a consequence of it?","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."},{"issue":"5054","key":"10.1016\/j.neuroscience.2024.12.027_b0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.027_b0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.027_b0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2007-11113","article-title":"Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease","volume":"11","author":"Jacob","year":"2007","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.027_b0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000172638.58172.5a","article-title":"Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures","volume":"65","author":"Jen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2024.12.027_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.89","article-title":"Aberrant iPSC-derived human astrocytes in Alzheimer's disease","author":"Jones","year":"2017","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.027_b0110","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of Excitatory Amino Acid Transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.027_b0115","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41598-018-19442-7","article-title":"Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain","volume":"8","author":"Kobayashi","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.027_b0120","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1038\/s41598-017-14176-4","article-title":"Impaired K(+) binding to glial glutamate transporter EAAT1 in migraine","volume":"7","author":"Kovermann","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.027_b0125","article-title":"Increased glutamate transporter-associated anion currents cause glial apoptosis in episodic ataxia 6. Brain","volume":"2","author":"Kovermann","year":"2020","journal-title":"Communications"},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.027_b0130","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/hipo.20015","article-title":"Developmental expression of glutamate transporters and glutamate dehydrogenase in astrocytes of the postnatal rat hippocampus","volume":"14","author":"Kugler","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuroscience.2024.12.027_b0135","doi-asserted-by":"crossref","DOI":"10.1007\/BF03401713","article-title":"Caspase-Mediated Apoptosis in Neuronal Excitotoxicity Triggered by Nitric Oxide","author":"Leist","year":"1997","journal-title":"Mol. Med."},{"issue":"5","key":"10.1016\/j.neuroscience.2024.12.027_b0140","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.14336\/AD.2023.0228","article-title":"CNTN1 Aggravates Neuroinflammation and Triggers Cognitive Deficits in Male Mice by Boosting Crosstalk between Microglia and Astrocytes","volume":"14","author":"Li","year":"2023","journal-title":"Aging Dis."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.027_b0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","article-title":"Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression","volume":"56","author":"Li","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101372","article-title":"Neuronal excitation\/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology","author":"Maest\u00fa","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0155","series-title":"Atlas of the human brain","author":"Mai","year":"2015"},{"issue":"22","key":"10.1016\/j.neuroscience.2024.12.027_b0160","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3390\/ijms20225671","article-title":"Excitatory amino acid transporters in physiology and disorders of the central nervous system","volume":"20","author":"Malik","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1358","key":"10.1016\/j.neuroscience.2024.12.027_b0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2010.08.020","article-title":"Age-dependent modifications in the mRNA levels of the rat excitatory amino acid transporters (EAATs) at 48hour reperfusion following global ischemia","volume":"28","author":"Montori","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.03.002","article-title":"The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics","author":"Pajarillo","year":"2019","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.neuroscience.2024.12.027_b0175","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1007\/s11064-009-9957-0","article-title":"Neuronal expression of splice variants of \u201cglial\u201d glutamate transporters in brains afflicted by Alzheimer's disease: unmasking an intrinsic neuronal property","volume":"34","author":"Pow","year":"2009","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.neuroscience.2024.12.027_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107068","article-title":"Excitatory amino acid transporter 1 supports adult hippocampal neural stem cell self-renewal","volume":"26","author":"Rieskamp","year":"2023","journal-title":"iScience."},{"issue":"3","key":"10.1016\/j.neuroscience.2024.12.027_b0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.neuroscience.2024.12.027_b0190","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.22-03-j0004.2002","article-title":"Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease","author":"Scott","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer's disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2024.12.027_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.neuroscience.2024.12.027_b0205","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1471-4159.2005.03370.x","article-title":"A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake","volume":"95","author":"Vallejo-Illarramendi","year":"2005","journal-title":"J. Neurochem."},{"issue":"8","key":"10.1016\/j.neuroscience.2024.12.027_b0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejmg.2016.06.003","article-title":"Duplications of SLC1A3: Associated with ADHD and autism","volume":"59","author":"van Amen-Hellebrekers","year":"2016","journal-title":"Eur. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.027_b0215","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/nprot.2006.354","article-title":"Immunohistochemical staining of post-mortem adult human brain sections","volume":"1","author":"Waldvogel","year":"2006","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.neuroscience.2024.12.027_b0220","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer's Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"8925","key":"10.1016\/j.neuroscience.2024.12.027_b0225","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(94)92338-8","article-title":"Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease","volume":"344","author":"West","year":"1994","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.neuroscience.2024.12.027_b0230","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1093\/brain\/aws255","article-title":"A point mutation associated with episodic ataxia 6 increases glutamate transporter anion currents","volume":"135","author":"Winter","year":"2012","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neuroscience.2024.12.027_b0235","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13005","article-title":"Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex","volume":"31","author":"Yeung","year":"2021","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuroscience.2024.12.027_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.702824","article-title":"EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer's Disease","volume":"15","author":"Yeung","year":"2021","journal-title":"Front. Cell. Neurosci."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452224007346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T21:58:13Z","timestamp":1738015093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452224007346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"alternative-id":["S0306452224007346"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.027","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulated excitatory amino acid transporter 1 (EAAT1) expression in the human medial temporal lobe in Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2024.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}